AdvaMedDX names BD's Vince Forlenza chairman
This article was originally published in SRA
AdvaMedDX, the branch of US medtech industry association AdvaMed that focuses on in vitro diagnostics, has appointed BD's Vince Forlenza as its new chairman. In addition, Andrew Fish has been named executive director of AdvaMedDX and senior executive vice president of AdvaMed.
Mr Forlenza is president and chief operating officer of BD, while Mr Fish was previously senior vice president, legal and government affairs, general counsel and secretary at the Consumer Healthcare Products Association.